USANA Health Sciences USNA Asia Pacific total — Net Sales
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by USANA Health Sciences in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: USANA Health Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about USANA Health Sciences's asia pacific total — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is USANA Health Sciences's asia pacific total — net sales?
- USANA Health Sciences (USNA) reported asia pacific total — net sales of $169.35M in Q1 2026.
- How has USANA Health Sciences's asia pacific total — net sales changed year-over-year?
- USANA Health Sciences's asia pacific total — net sales decreased by 2.3% year-over-year, from $173.41M to $169.35M.
- What is the long-term trend for USANA Health Sciences's asia pacific total — net sales?
- Over 4 years (2021 to 2025), USANA Health Sciences's asia pacific total — net sales has grown at a -10.2% compound annual growth rate (CAGR), from $963.19M to $627.16M.
- What does asia pacific total — net sales mean?
- This metric represents the total revenue generated from the sale of nutritional and personal-care products within the Asia Pacific geographic region. It serves as a key indicator of the company's market penetration, brand adoption, and direct-selling performance in this specific international territory. Tracking this figure allows investors to assess regional growth trends and the effectiveness of local distribution strategies relative to global operations.